Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caligiuri

Showing results (971-980 of 1,066) with videos related to

Pageof 107
Sort By:
Journal of Virology|October 20, 2021
The K18-Human ACE2 Transgenic Mouse Model Recapitulates Non-severe and Severe COVID-19 in Response to an Infectious Dose of the SARS-CoV-2 VirusWenjuan Dong, Heather Mead, Lei Tian, et al.
Nature Communications|December 1, 2018
Mutant p53s generate pro-invasive niches by influencing exosome podocalyxin levelsDavid Novo, Nikki Heath, Louise Mitchell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2022
NOTCH-Induced MDSC Recruitment after oHSV Virotherapy in CNS Cancer Models Modulates Antitumor ImmunotherapyYoshihiro Otani, Ji Young Yoo, Cole T Lewis, et al.
Haematologica|May 6, 2017
Prognostic and biologic significance of long non-coding RNA profiling in younger adults with cytogenetically normal acute myeloid leukemiaDimitrios Papaioannou, Deedra Nicolet, Stefano Volinia, et al.
Leukemia|December 12, 2013
GAS6 expression identifies high-risk adult AML patients: potential implications for therapySusan P Whitman, Jessica Kohlschmidt, Kati Maharry, et al.
Blood|October 28, 2011
ASXL1 mutations identify a high-risk subgroup of older patients with primary cytogenetically normal AML within the ELN Favorable genetic categoryKlaus H Metzeler, Heiko Becker, Kati Maharry, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2012
Age-related prognostic impact of different types of DNMT3A mutations in adults with primary cytogenetically normal acute myeloid leukemiaGuido Marcucci, Klaus H Metzeler, Sebastian Schwind, et al.
Blood|May 6, 2010
Mutations of the Wilms tumor 1 gene (WT1) in older patients with primary cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B studyHeiko Becker, Guido Marcucci, Kati Maharry, et al.
Blood|May 9, 2012
Clinical and pharmacodynamic activity of bortezomib and decitabine in acute myeloid leukemiaWilliam Blum, Sebastian Schwind, Somayeh S Tarighat, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 8, 2022
Hedgehog-interacting protein acts in the habenula to regulate nicotine intakeStephanie P B Caligiuri, William M Howe, Lauren Wills, et al.
Pageof 107

Showing results (971-980 of 1,066) with videos related to

Sort By:
Pageof 107
Journal of Virology|October 20, 2021
The K18-Human ACE2 Transgenic Mouse Model Recapitulates Non-severe and Severe COVID-19 in Response to an Infectious Dose of the SARS-CoV-2 VirusWenjuan Dong, Heather Mead, Lei Tian, et al.
Nature Communications|December 1, 2018
Mutant p53s generate pro-invasive niches by influencing exosome podocalyxin levelsDavid Novo, Nikki Heath, Louise Mitchell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2022
NOTCH-Induced MDSC Recruitment after oHSV Virotherapy in CNS Cancer Models Modulates Antitumor ImmunotherapyYoshihiro Otani, Ji Young Yoo, Cole T Lewis, et al.
Haematologica|May 6, 2017
Prognostic and biologic significance of long non-coding RNA profiling in younger adults with cytogenetically normal acute myeloid leukemiaDimitrios Papaioannou, Deedra Nicolet, Stefano Volinia, et al.
Leukemia|December 12, 2013
GAS6 expression identifies high-risk adult AML patients: potential implications for therapySusan P Whitman, Jessica Kohlschmidt, Kati Maharry, et al.
Blood|October 28, 2011
ASXL1 mutations identify a high-risk subgroup of older patients with primary cytogenetically normal AML within the ELN Favorable genetic categoryKlaus H Metzeler, Heiko Becker, Kati Maharry, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2012
Age-related prognostic impact of different types of DNMT3A mutations in adults with primary cytogenetically normal acute myeloid leukemiaGuido Marcucci, Klaus H Metzeler, Sebastian Schwind, et al.
Blood|May 6, 2010
Mutations of the Wilms tumor 1 gene (WT1) in older patients with primary cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B studyHeiko Becker, Guido Marcucci, Kati Maharry, et al.
Blood|May 9, 2012
Clinical and pharmacodynamic activity of bortezomib and decitabine in acute myeloid leukemiaWilliam Blum, Sebastian Schwind, Somayeh S Tarighat, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 8, 2022
Hedgehog-interacting protein acts in the habenula to regulate nicotine intakeStephanie P B Caligiuri, William M Howe, Lauren Wills, et al.
Pageof 107